Vincerx Pharma, Inc.
VINC
$0.05
-$0.005-9.09%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 4.44M | 4.99M | 10.09M | 16.32M | 5.11M |
Total Receivables | -- | 1.04M | 1.06M | 1.02M | 1.03M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 123.00K | 89.00K | 283.00K | 530.00K | 700.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 126.00K | 293.00K | 316.00K | 416.00K | 842.00K |
Total Current Assets | 4.69M | 6.41M | 11.75M | 18.28M | 7.68M |
|
|||||
Total Current Assets | 4.69M | 6.41M | 11.75M | 18.28M | 7.68M |
Net Property, Plant & Equipment | -- | -- | 1.52M | 1.79M | 2.06M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | 1.60M | 1.68M | 1.45M | 1.35M |
Total Assets | 4.69M | 8.01M | 14.95M | 21.53M | 11.08M |
|
|||||
Total Accounts Payable | 2.27M | 2.03M | 1.96M | 1.54M | 2.31M |
Total Accrued Expenses | 351.00K | 3.24M | 1.72M | 2.43M | 1.73M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | 1.27M | 1.24M | 1.20M |
Total Finance Division Other Current Liabilities | -- | 8.00K | 463.00K | 132.00K | 5.40M |
Total Other Current Liabilities | -- | 8.00K | 463.00K | 132.00K | 5.40M |
Total Current Liabilities | 2.62M | 5.28M | 5.42M | 5.33M | 10.63M |
|
|||||
Total Current Liabilities | 2.62M | 5.28M | 5.42M | 5.33M | 10.63M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | 365.00K | 697.00K | 1.02M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | 50.00K | 50.00K | 50.00K |
Total Liabilities | 2.62M | 5.28M | 5.84M | 6.08M | 11.71M |
|
|||||
Common Stock & APIC | 196.08M | 191.79M | 190.20M | 188.77M | 170.86M |
Retained Earnings | -194.19M | -189.19M | -181.19M | -173.35M | -171.54M |
Treasury Stock & Other | 170.00K | 119.00K | 104.00K | 24.00K | 60.00K |
Total Common Equity | 2.07M | 2.72M | 9.11M | 15.45M | -622.00K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 2.07M | 2.72M | 9.11M | 15.45M | -622.00K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 2.07M | 2.72M | 9.11M | 15.45M | -622.00K |
|